What Happens in the Brain With Tourette Syndrome?

Tourette Syndrome (TS) is a neurodevelopmental condition recognized by the presence of involuntary, rapid, and repetitive movements and vocalizations, known as motor and vocal tics. These movements are not a matter of willpower but are rooted in differences in how the brain develops and communicates. Research shows that TS is fundamentally a disorder of brain function and communication pathways.

Key Brain Regions Central to Tics

The structures most consistently implicated in the generation of tics are deep within the brain, forming a system that regulates movement and habit formation. This includes the Basal Ganglia, a collection of subcortical nuclei responsible for initiating and suppressing movements. Specifically, the Striatum, composed of the Caudate nucleus and Putamen, acts as the primary input center for this system, receiving signals from the outer layer of the brain, the Cortex.

Evidence from imaging studies suggests structural differences in these areas, such as a smaller Caudate nucleus. Studies have revealed a significant reduction in the number of specialized brain cells called interneurons within the Striatum, which are normally responsible for regulating electrical activity. This loss of inhibitory control within the Basal Ganglia helps explain why the brain struggles to prevent unwanted movements.

The Thalamus also plays a regulatory role, acting as a relay station by projecting signals back to the Motor and Prefrontal Cortices, which are responsible for planning and executing voluntary movement. In TS, the Prefrontal Cortex, which manages cognitive control and impulse suppression, may show differences, sometimes displaying a larger volume as a possible adaptive mechanism to manage tics. The Motor Cortex, which directly executes movements, also exhibits excessive activity during tics, indicating that the final motor command is overactive.

The Role of Neurotransmitters in TS

Communication between these key brain regions is managed by chemical messengers called neurotransmitters, and abnormalities in these chemicals are a significant factor in TS. The most robust evidence points to dysregulation of the neurotransmitter Dopamine, particularly within the Basal Ganglia. Dopamine is a chemical that influences movement, motivation, and reward, and its signaling appears to be overactive or hypersensitive in the striatum of people with TS.

This dysregulation is not necessarily an excess of Dopamine itself but rather an issue with how the brain’s receptors respond to it, leading to a state of excessive activity. This overactive dopaminergic transmission in the Striatum is thought to contribute to the disinhibition of motor pathways, making the initiation of movement easier and the suppression of unwanted movements harder. The effectiveness of medications that block Dopamine receptors in reducing tics strongly supports this theory.

Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the brain, and its function is to dampen neural activity. Reduced GABA concentrations, particularly in the motor and somatosensory cortices, suggest a failure of the brain’s natural ability to inhibit unwanted signals. Serotonin, a chemical involved in mood and impulse control, also shows altered activity, often relating more closely to co-occurring conditions like anxiety and obsessive-compulsive disorder.

Neural Circuitry and Connectivity Issues

The structures and chemical messengers described are connected in a complex network known as the Cortico-Striatal-Thalamo-Cortical (CSTC) loop. This loop is the functional mechanism through which the brain selects and executes desired movements while suppressing all others. In a typical brain, the CSTC loop functions like a gate, tightly controlling which motor commands pass from the cortex to the muscles.

The Basal Ganglia contains both a “direct” pathway, which facilitates movement, and an “indirect” pathway, which inhibits movement. In TS, the balance between these two pathways is disrupted, often favoring the direct, movement-facilitating pathway due to Dopamine and GABA dysregulation. This imbalance results in reduced inhibition of the Thalamus, leading to a failure of the brain’s “suppression filter” and the involuntary expression of tics.

A unique characteristic of TS is the “premonitory urge,” a strong, uncomfortable sensory feeling that precedes the tic. This urge is thought to originate in sensory-related brain areas, such as the Somatosensory Cortices and the Insula. These regions process body sensations and internal states, and their abnormal activation may create the mounting tension that is temporarily relieved only by executing the tic. Functional imaging studies show that tics result from excessive activity in the motor pathways combined with reduced activity in the control portions of the CSTC circuits, such as the Caudate nucleus and parts of the Prefrontal Cortex.

Translating Brain Research into Therapeutic Approaches

The knowledge that Dopamine signaling is overactive in the Basal Ganglia led to the use of medications that block Dopamine-2 (D2) receptors. These D2 blocking agents work to normalize the excessive signaling within the CSTC loop, which can significantly reduce tic severity.

The recognition that tics are related to a lack of inhibitory control within the CSTC loop also underpins the success of behavioral interventions. Comprehensive Behavioral Intervention for Tics (CBIT) is a non-pharmacological approach that trains individuals to recognize the premonitory urge. By recognizing this sensory signal, the individual learns to perform a competing, voluntary movement incompatible with the tic, engaging the brain’s control circuits to override the dysfunctional loop.

For the most severe and treatment-resistant cases, surgical options like Deep Brain Stimulation (DBS) are available, which are precise applications of the circuit-based model of TS. DBS involves implanting an electrode into specific targets within the Basal Ganglia or Thalamus to deliver continuous electrical impulses. This electrical stimulation works to modulate the abnormal activity in the CSTC loop, helping to restore the normal balance of excitation and inhibition and thereby suppress tics.